ClinicalTrials.Veeva

Menu

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life (PanFit)

B

British Columbia Cancer Agency

Status

Not yet enrolling

Conditions

Hand Grip Strength
Pancreatic Ductal Adenocarcinoma (PDAC)

Treatments

Device: Hand grip strength assessments using a dynamometer

Study type

Interventional

Funder types

Other

Identifiers

NCT07255001
H25-00754

Details and patient eligibility

About

The goal of this clinical trial is to measure hand grip strength in adults with pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are:

  • Is it feasible to measure hand grip strength as part of a clinic visit?
  • Are changes in hand grip strength related to changes in body composition?
  • Is hand grip strength related to a person's well-being?
  • Is hand grip strength related to how a tumour responds to treatment?

Participants will squeeze a device with their hand to measure their hand grip strength and complete questionnaires about their well-being when they are seen in clinic for their regular medical care for PDAC.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older.
  • Histological and/or radiological diagnosis of resectable, non-resectable, or metastatic PDAC. For resectable PDAC, adjuvant setting only.
  • ECOG performance status 0-2.
  • Life expectancy greater than 6 months as judged by the investigator.
  • Planned for treatment, either as part of routine care or in combination with an investigational agent within another study.
  • Ability to hold a dynamometer with one hand.

Exclusion criteria

  • Individuals with CT imaging performed outside of Vancouver, BC, Canada.
  • Individuals who are unfit to undergo CT imaging of the third lumbar vertebra (L3).
  • Individuals who are currently participating in a structured moderate intensity resistance training program.
  • Individuals who are otherwise judged by the investigator to be unfit to proceed with this protocol.
  • Unable to comply with study assessments and follow-up.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Main Study Arm
Experimental group
Description:
The study arm all participants are enrolled into. Participants will complete hand grip strength assessments and questionnaires.
Treatment:
Device: Hand grip strength assessments using a dynamometer

Trial contacts and locations

1

Loading...

Central trial contact

Daniel J Renouf, MD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems